Staphylococcal enterotoxin C (Zhejiang Wanxiang Pharmaceutical)

金葡素C (浙江万翔药业股份有限公司)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStaphylococcal enterotoxin C (Zhejiang Wanxiang Pharmaceutical)
Drug Alias NameEngefei
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsNeutropeniaBone Diseases
Global Approved IndicationsNeutropeniaBone Diseases
Approved Indications in ChinaNeutropeniaBone Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeutropeniaBone Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL01XX
Related LinksN/A